State Medicaid Drug Review Responsibilities

As of July 1, 2019

Location	State Entity Responsible for Review of New Drugs for Preferred Drug List Placement	State Entity Responsible for Developing Step Therapy Criteria	State Entity Responsible for Developing Prior Authoriztion Criteria	State Entity Responsible for Review of Orphan/Expedited Review Drugs
United States	-	-	-	-
Alabama	P&T Committee	Medicaid agency	Medicaid agency	Medicaid agency
Alaska	P&T Committee	DUR Board	DUR Board	Medicaid agency
Arizona	P&T Committee	P&T Committee	Other	P&T Committee
Arkansas	Other	N/A	DUR Board	DUR Board
California	Medicaid agency	Medicaid agency	Medicaid agency	Medicaid agency
Colorado	P&T Committee	DUR Board	DUR Board	DUR Board
Connecticut	P&T Committee	Other	Medicaid agency	Other
Delaware	P&T Committee	DUR Board	Medicaid agency	Medicaid agency
District of Columbia	P&T Committee	DUR Board	DUR Board	DUR Board
Florida	P&T Committee	DUR Board	Medicaid agency	Medicaid agency
Georgia	DUR Board	Medicaid agency	Medicaid agency	DUR Board
Hawaii	N/A -- No PDL	N/A	N/A	Medicaid agency
Idaho	P&T Committee	Medicaid agency	Medicaid agency	P&T Committee
Illinois	P&T Committee	DUR Board	Medicaid agency	P&T Committee
Indiana	Other	Other	Other	Other
Iowa	P&T Committee	P&T Committee	DUR Board	Other
Kansas	Medicaid agency	Medicaid agency	Other	Other
Kentucky	P&T Committee	P&T Committee	P&T Committee	P&T Committee
Louisiana	P&T Committee	N/A	Other	P&T Committee
Maine	P&T Committee	P&T Committee	P&T Committee	DUR Board
Maryland	P&T Committee	Medicaid agency	Medicaid agency	Other
Massachusetts	Medicaid agency	Medicaid agency	Medicaid agency	Medicaid agency
Michigan	Other	Other	Other	Other
Minnesota	P&T Committee	N/A	P&T Committee	P&T Committee
Mississippi	P&T Committee	Other	Other	Other
Missouri	Medicaid agency	Medicaid agency	Medicaid agency	Medicaid agency
Montana	Medicaid agency	DUR Board	DUR Board	DUR Board
Nebraska	P&T Committee	Other	Other	Medicaid agency
Nevada	P&T Committee	Medicaid agency	DUR Board	DUR Board
New Hampshire	Medicaid agency	Medicaid agency	Medicaid agency	Other
New Jersey	N/A -- No PDL	DUR Board	DUR Board	Medicaid agency
New Mexico	N/A -- No PDL	N/A	Other	Other
New York	DUR Board	DUR Board	DUR Board	Other
North Carolina	P&T Committee	Medicaid agency	Medicaid agency	PT Committee
North Dakota	DUR Board	DUR Board	DUR Board	Medicaid agency
Ohio	P&T Committee	P&T Committee	P&T Committee	Medicaid agency
Oklahoma	DUR Board	DUR Board	DUR Board	DUR Board
Oregon	P&T Committee	P&T Committee	P&T Committee	P&T Committee
Pennsylvania	P&T Committee	P&T Committee	DUR Board	DUR Board
Rhode Island	P&T Committee	P&T Committee	P&T Committee	Other
South Carolina	P&T Committee	Medicaid agency	Medicaid agency	Medicaid agency
South Dakota	N/A -- No PDL	P&T Committee	P&T Committee	P&T Committee
Tennessee	P&T Committee	P&T Committee	P&T Committee	P&T Committee
Texas	DUR Board	DUR Board	DUR Board	Medicaid agency
Utah	NR		NR	NR
Vermont	DUR Board	DUR Board	DUR Board	DUR Board
Virginia	P&T Committee	P&T Committee	Other	DUR Board
Washington	Other	Medicaid agency	Medicaid agency	Medicaid agency
West Virginia	P&T Committee	DUR Board	DUR Board	DUR Board
Wisconsin	Medicaid agency	Medicaid agency	Medicaid agency	Medicaid agency
Wyoming	P&T Committee	P&T Committee	P&T Committee	Medicaid agency

Topics

Policy Research

Polling

Health News

Data & Features

For Media

About

State Medicaid Drug Review Responsibilities

Data are loading

State Medicaid Drug Review Responsibilities

As of July 1, 2019

Topics